id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-331790-0w0pjjg1	Abu Jawdeh, Bassam G.	COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management and Operational Challenges	2020-07-17		.txt	text/plain	3057	204	47	This review summarizes the published COVID-19 literature as it relates to outcomes and immunosuppression management in kidney transplant recipients. These multiple studies have elucidated that COVID-19 is a systemic disease that often manifests with gastrointestinal (GI) symptoms, liver injury, cardiac involvement, encephalitis, atypical stroke, acute kidney injury (AKI) in addition to endothelial cell injury and coagulopathy -the likely mediators of multi-organ involvement (3) (4) (5) (6) (7) (8) . In a 36-patient study, the median age was 60 years, 72% were male, 39% were African American and 75% received deceased-donor kidney transplants (DDKT)(9). Notably, the Columbia transplant program adopts an early steroid withdrawal strategy, however their sample was enriched with patients on prednisone maintenance (67%) which confirms the plausible role of enhanced immunosuppression as a susceptibility factor.	./cache/cord-331790-0w0pjjg1.txt	./txt/cord-331790-0w0pjjg1.txt